Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 15Sanofi
02 1Biocon
03 1Biocon Biologics
04 6Biosimilar Collaborations Ireland Limited
05 134Novo Nordisk
06 1ORIFARM GROUP AS
01 4CAT
02 1Flextouch Injectable Solution In Pre-Filled Pen
03 1INJ
04 10INJECTABLE;SUBCUTANEOUS
05 3INJECTION;SOLUTION
06 11Injectable Solution
07 1Injectable Solution In A Pre-Filled Pen
08 3Injectable Solution In Cartridge
09 1Injectable Solution In Pre-Filled Pen
10 2Injectable Solution In Vial
11 1Injectable Suspension
12 3Injection
13 7Injection Solution
14 1Insulin Aspart 160U 1,6Ml 5 Units Parenteral Use
15 2Insulin Aspart 300Iu 3Ml 5 Units Parenteral Use
16 3PED
17 2PFP
18 1Penfill Injectable Solution In Cartridge
19 1Pumpcart Injectable Solution In Cartridge
20 9SOLUTION
21 1SOLUTION;INTRAVENOUS, SUBCUTANEOUS
22 3SOLUTION;SUBCUTANEOUS
23 2SUSPENSION
24 1Soluble Insulin Aspart+Insulin Aspart Crystallised Protamino 30/70 300Iu 3Ml 5 Units Parenteral Use
25 1Soluble Insulin Aspart+Insulin Aspart Crystallised Protamino 50/50 300Iu 3Ml 5 Units Parenteral Use
26 1Soluble Insulin Aspart+Insulin Aspart Crystallised Protamino 70/30 300Iu 3Ml 5 Units Parenteral Use
27 57Solution For Injection
28 21Suspension For Injection
29 4Blank
01 11Allowed
02 22Approved
03 9Authorized
04 6Deregistered
05 11Marketed
06 10Originator
07 46Prescription
08 11Schedule D
09 32Blank
01 4FIASP
02 1FIASP FLEXTOUCH
03 1FIASP PENFILL
04 17Fiasp
05 1Fiasp Eml ultra-fast-acting PumpCart
06 1Fiasp Flextouch
07 2Fiasp Penfill
08 2Fiasp Pumpcart
09 1Fiasp ultra-fast-acting
10 1Fiasp ultra-fast-acting FlexTouch
11 1Fiasp ultra-fast-acting Penfill
12 3Insulin Aspart Sanofi
13 3Insulin Aspart "Sanofi"
14 1Insulin NovoNordisk NovoRapid
15 1Insulin NovoNordisk NovoRapid FlexPen
16 1Insulin NovoNordisk NovoRapid FlexTouch
17 1Insulin NovoNordisk NovoRapid Penfill
18 1Insulin NovoNordisk NovoRapid PumpCart Eml
19 2KIRSTY
20 6Kirsty
21 1MERILOG
22 1MERILOG SOLOSTAR
23 1NOVOLOG
24 1NOVOLOG FLEXPEN
25 1NOVOLOG FLEXTOUCH
26 1NOVOLOG INNOLET
27 1NOVOLOG MIX 50/50
28 1NOVOLOG MIX 70/30
29 1NOVOLOG MIX 70/30 FLEXPEN
30 2NOVOLOG MIX 70/30 PENFILL
31 1NOVOLOG PENFILL
32 2NOVOMIX 30
33 2NOVORAPID
34 2NovoMix 30
35 1NovoMix 30 FlexPen
36 1NovoMix 30 Penfill 3 mL
37 5NovoRapid
38 1NovoRapid FlexPen
39 2NovoRapid Flexpen
40 1NovoRapid Penfill
41 1NovoRapid Penfill 3 mL
42 1NovoRapid PumpCart
43 1NovoRapid® FlexPen®
44 1NovoRapid® Penfill®
45 3Novomix
46 1Novomix 30
47 3Novomix 30 Flexpen
48 1Novomix 30 Flexpen 100 U/ml
49 2Novomix 30 Novolet
50 3Novomix 30 Penfill
51 1Novomix 30 Penfill 100 U/ml
52 3Novomix 50 Flexpen
53 3Novomix 50 Penfill
54 3Novomix 70 Flexpen
55 2Novomix 70 Penfill
56 5Novorapid
57 1Novorapid Flex Touch
58 5Novorapid Flexpen
59 2Novorapid Flextouch
60 3Novorapid Innolet
61 1Novorapid Novolet
62 4Novorapid Penfill
63 4Novorapid Pumpcart
64 1Novorapidfill
65 1RYZODEG 70/30
66 1Ryzodeg
67 1Ryzodeg 100 Flextouch
68 1Ryzodeg 100 Penfill
69 1Ryzodeg 100 Ãœhikut/Ml Flexpen
70 1Ryzodeg 100 Ãœhikut/Ml Flextouch
71 1Ryzodeg 100 Ãœhikut/Ml Penfill
72 1Ryzodeg FlexTouch
73 1Ryzodeg Flexpen
74 1Ryzodeg Flextouch
75 3Ryzodeg Penfill
76 3Ryzodeg®
77 3TRURAPI
78 4Truvelog Mix 30
01 7Australia
02 11Canada
03 26Denmark
04 20Estonia
05 6Italy
06 2Moldova
07 11Norway
08 10South Africa
09 9Spain
10 28Sweden
11 11Switzerland
12 17USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : USA
Brand Name : MERILOG
Dosage Form : INJECTION;SOLUTION
Dosage Strength : 10ML(100UNITS/ML)
Packaging :
Approval Date :
Application Number : 761325
Regulatory Info :
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : USA
Brand Name : MERILOG SOLOSTAR
Dosage Form : INJECTION;SOLUTION
Dosage Strength : 3ML(100UNITS/ML)
Packaging :
Approval Date :
Application Number : 761325
Regulatory Info :
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Insulin Aspart Sanofi
Dosage Form : Injectable Solution
Dosage Strength : 100E/ml
Packaging :
Approval Date : 21/04/2021
Application Number : 20200727000046
Regulatory Info : Approved
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Insulin Aspart Sanofi
Dosage Form : Solution For Injection
Dosage Strength : 100E/ml
Packaging :
Approval Date : 25/06/2020
Application Number : 20190604000057
Regulatory Info : Approved
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Insulin Aspart Sanofi
Dosage Form : Solution For Injection
Dosage Strength : 100E/ml
Packaging :
Approval Date : 25/06/2020
Application Number : 20190604000064
Regulatory Info : Approved
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Deregistered
Registration Country : Sweden
Insulin Aspart (Soluble); Insulin Aspart Protamine
Brand Name : Truvelog Mix 30
Dosage Form : Suspension For Injection
Dosage Strength : 100E/ml
Packaging :
Approval Date : 25/04/2022
Application Number : 20210429000121
Regulatory Info : Deregistered
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Deregistered
Registration Country : Sweden
Insulin Aspart (Soluble); Insulin Aspart Protamine
Brand Name : Truvelog Mix 30
Dosage Form : Injectable Solution
Dosage Strength : 100E/ml
Packaging :
Approval Date : 25/04/2022
Application Number : 20210429000114
Regulatory Info : Deregistered
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : TRURAPI
Dosage Form : SOLUTION
Dosage Strength : 100UNIT/ML
Packaging :
Approval Date :
Application Number : 2506564
Regulatory Info : Schedule D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : TRURAPI
Dosage Form : SOLUTION
Dosage Strength : 100UNIT/ML
Packaging :
Approval Date :
Application Number : 2506572
Regulatory Info : Schedule D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : TRURAPI
Dosage Form : SOLUTION
Dosage Strength : 100UNIT/ML
Packaging :
Approval Date :
Application Number : 2529254
Regulatory Info : Schedule D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Insulin Aspart \"Sanofi\"
Dosage Form : Injection Solution
Dosage Strength : 100 U/ml
Packaging :
Approval Date : 21-02-2021
Application Number : 28106486720
Regulatory Info : Prescription
Registration Country : Denmark
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Insulin Aspart \"Sanofi\"
Dosage Form : Solution For Injection
Dosage Strength : 100 U/ml
Packaging :
Approval Date : 25-06-2020
Application Number : 28106283519
Regulatory Info : Prescription
Registration Country : Denmark
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Insulin Aspart \"Sanofi\"
Dosage Form : Solution For Injection
Dosage Strength : 100 U/ml
Packaging :
Approval Date : 25-06-2020
Application Number : 28106474719
Regulatory Info : Prescription
Registration Country : Denmark
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Truvelog Mix 30
Dosage Form : Injectable Suspension
Dosage Strength : 100 units/ml
Packaging :
Approval Date : 25-04-2022
Application Number : 28106607521
Regulatory Info : Prescription
Registration Country : Denmark
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Truvelog Mix 30
Dosage Form : Suspension For Injection
Dosage Strength : 100 units/ml
Packaging :
Approval Date : 25-04-2022
Application Number : 28106607621
Regulatory Info : Prescription
Registration Country : Denmark
Regulatory Info :
Registration Country : USA
Brand Name : NOVOLOG
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 1000 UNITS/10ML (100 UNITS/ML)
Packaging :
Approval Date :
Application Number : 20986
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NOVOLOG PENFILL
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)
Packaging :
Approval Date :
Application Number : 20986
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NOVOLOG FLEXPEN
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)
Packaging :
Approval Date :
Application Number : 20986
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NOVOLOG INNOLET
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)
Packaging :
Approval Date :
Application Number : 20986
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NOVOLOG FLEXTOUCH
Dosage Form : INJECTABLE;SUBCUTANEOUS
Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)
Packaging :
Approval Date :
Application Number : 20986
Regulatory Info :
Registration Country : USA
